The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
MHC class I molecules and kirs in human history, health and survival
Abstract
MHC class I molecules are ligands for the killer-cell immunoglobulin-like receptors (KIRs), which are expressed by natural killer cells and T cells. The interactions between these molecules contribute to both innate and adaptive immunity. KIRs and MHC class I molecules are encoded by unlinked polymorphic gene families that distinguish all but the most related individuals. Combinations of MHC class I and KIR variants influence resistance to infections, susceptibility to autoimmune diseases and complications of pregnancy, as well as outcome after haematopoietic stem-cell transplantation. Such correlations raise the possibility that interplay between KIR and MHC class I polymorphisms has facilitated human survival in the presence of epidemic infections and has influenced both reproduction and population growth.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly significant differences were seen following genotyping of the mothers, suggesting a broad influence of the genetic background of NK activity, especially given that KIR/HLA complexes are expressed and active in the placenta (Guerini et al, 2014;Parham, 2005).”
From The Role of the Immune System in Autism Spectrum Disorder (2017) · cites this paper as Parham, 2005
Citations
Cites
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Natural killer cells and pregnancy
Moffett-King, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri886 · Cited by 1,235
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C., Gao, X., Astemborski, J. A., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M. W., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,178
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K. W., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,173
Hiby, S. E., Walker, J. J., O’Shaughnessy, K. M., Redman, C. W. G., Carrington, M. N., Trowsdale, J., & Moffett, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041214 · Cited by 1,134
Human Diversity in Killer Cell Inhibitory Receptor Genes
Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B. C., Tyan, D. B., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80394-5 · Cited by 1,060
Self-citationKIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 984
Self-citationAshkar, A. A., Santo, J. P. D., & Croy, B. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.259 · Cited by 847
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,000
Wang, J., Urbanowicz, R. A., Tighe, P. J., Todd, I., Corne, J. M., & Fairclough, L. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058556 · Cited by 42
Amazonian Amerindians exhibit high variability of KIR profiles
Ewerton, P. D., Leite, M. D. M., Magalhães, M., Sena, L. D. S., & dos Santos, E. J. M. (2007) · Immunogenetics · doi:10.1007/s00251-007-0229-3 · Cited by 42
KIR receptors and HLA‐C in the maintenance of pregnancy
Flores, A. C., Marcos, C. Y., Paladino, N., Arruvito, L., Williams, F., Middleton, D., & Fainboim, L. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.762_8.x · Cited by 42
Pascal, V., Stulberg, M. J., & Anderson, S. K. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00452.x · Cited by 42
Genetically engineered hypoimmunogenic cell therapy
Hotta, A., Schrepfer, S., & Nagy, A. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00219-9 · Cited by 44
Sullivan, E. M., Jeha, S., Kang, G., Cheng, C., Rooney, B., Holladay, M. S., Bari, R., Schell, S. S., Tuggle, M., Pui, C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0479 · Cited by 41
Pesce, S., Thorén, F. B., Cantoni, C., Prato, C., Moretta, L., Moretta, A., & Marcenaro, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00510 · Cited by 41
Zuo, J., Willcox, C. R., Mohammed, F., Davey, M. S., Hunter, S., Khan, K., Antoun, A., Katakia, P., Croudace, J. E., Inman, C. F., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aai8904 · Cited by 41
Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell
Lin, C., & Zhang, J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.01.005 · Cited by 41
Kveberg, L., Bäck, C. J., Dai, K., Inngjerdingen, M., Rolstad, B., Ryan, J. C., Vaage, J. T., & Naper, C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4133 · Cited by 41
Why is the fetal allograft not rejected?1
Davies, C. J. (2007) · Journal of Animal Science · doi:10.2527/jas.2006-492 · Cited by 41
Exome capture from saliva produces high quality genomic and metagenomic data
Kidd, J. M., Sharpton, T. J., Bobo, D., Norman, P. J., Martin, A. R., Carpenter, M. L., Sikora, M., Gignoux, C. R., Nemat‐Gorgani, N., Adams, A., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-262 · Cited by 42
Self-citationRheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy
Yang, Y., Hong, Q., Zhang, X., & Liu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1331486 · Cited by 43
The chicken leukocyte receptor cluster
Viertlboeck, B. C., & Göbel, T. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.07.001 · Cited by 41
Jennes, W., Verheyden, S. J., Mertens, J. W., Camara, M., Seydi, M., Dièye, T. N., Mboup, S., Demanet, C. J., & Kestens, L. (2012) · Blood · doi:10.1182/blood-2012-09-455352 · Cited by 40
KIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand
Nemat‐Gorgani, N., Edinur, H. A., Hollenbach, J. A., Traherne, J. A., Dunn, P. P. J., Chambers, G. K., Parham, P., & Norman, P. J. (2014) · Immunogenetics · doi:10.1007/s00251-014-0794-1 · Cited by 40
Self-citationEpigenetic mechanisms of age-dependent KIR2DL4 expression in T cells
Li, G., Weyand, C. M., & Goronzy, J. J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807583 · Cited by 40
Horowitz, A., Guethlein, L. A., Nemat‐Gorgani, N., Norman, P. J., Cooley, S., Miller, J. S., & Parham, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401990 · Cited by 40
Self-citationKijak, G. H., Walsh, A. M., Koehler, R. N., Moqueet, N., Eller, L. A., Eller, M. A., Currier, J., Wang, Z., Wabwire‐Mangen, F., Kibuuka, H. N., et al. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2008.01192.x · Cited by 40
Natural killer cells in immunodefense against infective agents
Zucchini, N., Crozat, K., Baranek, T., Robbins, S. H., Altfeld, M. A., & Dalod, M. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.6.867 · Cited by 44
Analysis of KIR gene frequencies and HLA class I genotypes in breast cancer and control group
Jobim, M. R. S. L., Jobim, M., Salim, P. H., Portela, P., Jobim, L. F. J., Leistner‐Segal, S., Bittelbrunn, A. C. D. C., Menke, C. H., Biazús, J. V., Roesler, R., et al. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.06.021 · Cited by 40
Tanaka, J., MORISHIMA, Y., Takahashi, Y., Yabe, T., Oba, K., Takahashi, S., Taniguchi, S., Ogawa, H., Onishi, Y., Miyamura, K., et al. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.62 · Cited by 39
Hiby, S. E., Bonab, M. A., Farrell, L. E., Single, R. M., Balloux, F., Carrington, M. N., & Moffett, A. (2009) · Immunogenetics · doi:10.1007/s00251-009-0408-5 · Cited by 39
Forslund, E., Guldevall, K., Olofsson, P. E., Frisk, T. W., Christakou, A. E., Wiklund, M., & Önfelt, B. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00300 · Cited by 39
Ureshino, H., Shindo, T., Kojima, H., Kusunoki, Y., Miyazaki, Y., Tanaka, H., Saji, H., Kawaguchi, A., & Kimura, S. H. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0462 · Cited by 39
Immunodominance Hierarchies and Gender Bias in Direct TCD8-Cell Alloreactivity
Mifsud, N. A., Purcell, A. W., Chen, W., Holdsworth, R. F., Tait, B. D., & McCluskey, J. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02044.x · Cited by 39
Association between killer‐cell immunoglobulin‐like receptor genotypes and leprosy in Brazil
Franceschi, D. S. A., Mazini, P. S., Rudnick, C. C. C., Sell, A. M., Tsuneto, L. T., de Melo, F. C., Braga, M. A., Peixoto, P. R., & Visentainer, J. E. L. (2008) · Tissue Antigens · doi:10.1111/j.1399-0039.2008.01127.x · Cited by 39
Human Leukocyte Antigens in Pregnancy and Preeclampsia
Aisagbonhi, O. A., & Morris, G. P. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.884275 · Cited by 40
Whole genome sequencing predicts novel human disease models in rhesus macaques
Bimber, B. N., Ramakrishnan, R., Cervera‐Juanes, R. P., Madhira, R., Peterson, S. M., Norgren, R. B., & Ferguson, B. M. (2017) · Genomics · doi:10.1016/j.ygeno.2017.04.001 · Cited by 38
Guillamón, C. F., Martínez‐Sánchez, M. V., Gimeno, L., Mrowiec, A., Martínez-García, J., Server-Pastor, G., Martínez‐Escribano, J., Torroba, A., Ferri, B., Abellán, D., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0022 · Cited by 38
Pregnancy immunogenetics: NK cell education in the womb?
Parham, P., & Guethlein, L. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci44559 · Cited by 37
Self-citationGenetics of multiple sclerosis
Hoppenbrouwers, I. A., & Hintzen, R. Q. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.017 · Cited by 39
A role for calreticulin in the pathogenesis of rheumatoid arthritis
Holoshitz, J., de Almeida, D. E., & Ling, S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05745.x · Cited by 39
Comparison of the rapidly evolving KIR locus in Parsis and natives of India
Kulkarni, S., Single, R. M., Martin, M. P., Rajalingam, R., Badwe, R. A., Joshi, N., & Carrington, M. N. (2008) · Immunogenetics · doi:10.1007/s00251-008-0279-1 · Cited by 37
The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression
Kandilarova, S. M., Paschen, A., Mihaylova, A., Ivanova, M., Schadendorf, D., & Naumova, E. J. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0437-3 · Cited by 36
Lin, X., Xie, Y., Zhao, S.-J., Liu, C., Mor, G., & Liao, A. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73616 · Cited by 36
Molecular mechanisms of allorecognition in a basal chordate
McKitrick, T. R., & Tomaso, A. W. D. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.12.001 · Cited by 36
Lank, S. M., Golbach, B. A., Creager, H. M., Wiseman, R. W., Keskin, D. B., Reinherz, E. L., Brusić, V., & O’Connor, D. H. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-378 · Cited by 36
Muñoz, M. E. C., Valenzuela‐Vázquez, L., Sánchez‐Herrera, J., & Tapia, J. S.-O. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0618-224rr · Cited by 38
On behalf of the Acute Leukemia Working Party (ALWP) and Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT), Lorentino, F., Labopin, M., Ciceri, F., Vago, L., Fleischhauer, K., Afanasyev, B. V., Kröger, N. M., Cornelissen, J. J., Lovira, M., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0863-4 · Cited by 36
Marin, W. M., Dandekar, R., Augusto, D. G., Yusufali, T., Heyn, B., Hofmann, J. A., Lange, V., Sauter, J., Norman, P. J., & Hollenbach, J. A. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008904 · Cited by 36
Middleton, D., Vilchez, J. R., Cabrera, T., Meenagh, A., Williams, F., Halfpenny, I. A., Maleno, I., Ruiz‐Cabello, F., López‐Nevot, M. Á., & Garrido, F. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00792.x · Cited by 36
KIR Gene Mismatching and KIR/C Ligands in Liver Transplantation
Legáz, I., López-Álvarez, M. R., Campillo, J. A., Moya‐Quiles, M. R., Bolarín, J. M., de la Peña, J., Salgado, G., Gimeno, L., García-Alonso, A. M., Muro, M., et al. (2013) · Transplantation · doi:10.1097/tp.0b013e318286486c · Cited by 36
Contribution of functional KIR3DL1 to ankylosing spondylitis
Zvyagin, I. V., Mamedov, I. Z., Britanova, O. V., Staroverov, D. B., Nasonov, E. L., Bochkova, A. G., Chkalina, A. V., Kotlobay, A. A., Korostin, D. O., Rebrikov, D. V., et al. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.42 · Cited by 36
Karabon, L., Jedynak, A., Giebel, S., Wołowiec, D., Kiełbiński, M., Woszczyk, D., Kapelko-Slowik, K. L., Kuliczkowski, K., & Frydecka, I. (2011) · Tissue Antigens · doi:10.1111/j.1399-0039.2011.01721.x · Cited by 36
Rhesus Macaque Inhibitory and Activating KIR3D Interact with Mamu-A–Encoded Ligands
Rosner, C., Kruse, P. H., Hermes, M., Otto, N., & Walter, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002634 · Cited by 36
Malmberg, K., Sohlberg, E., Goodridge, J. P., & Ljunggren, H. (2017) · Immunogenetics · doi:10.1007/s00251-017-1011-9 · Cited by 36
Chang, C., & Ferrone, S. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.001 · Cited by 36
Cantoni, C., Falco, M., Vitale, M., Pietra, G., Munari, E., Pende, D., Mingari, M. C., Sivori, S., & Moretta, L. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2378520 · Cited by 36
Clathrin light chains’ role in selective endocytosis influences antibody isotype switching
Wu, S., Majeed, S. R., Evans, T. M., Camus, M. D., Wong, N. M. L., Schollmeier, Y., Park, M., Muppidi, J. R., Reboldi, A., Parham, P., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611189113 · Cited by 35
Self-citationCalvo, T., Reina-Ortiz, C., Giraldos, D., Gascón, M., Woods, D., Asenjo, J., Marco-Brualla, J., Azaceta, G., Izquierdo, I., Palomera, L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76051-z · Cited by 35
Identification of distal KIR promoters and transcripts
Stulberg, M. J., Wright, P. W., Dang, H., Hanson, R. J., Miller, J. S., & Anderson, S. K. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364363 · Cited by 35
Gagne, K., Willem, C., Legrand, N., Djaoud, Z., David, G., Rettman, P., Bressollette‐Bodin, C., Senitzer, D., Esbelin, J., Cesbron‐Gautier, A., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201243007 · Cited by 35
Lundwall, Å., Clauss, A., & Olsson, A. Y. (2006) · Biological Chemistry · doi:10.1515/bc.2006.032 · Cited by 36
Protective KIR–HLA interactions for HCV infection in intravenous drug users
Zúñiga, J., Romero, V. A., Azócar, J. A., Terreros, D. A., Vargas-Rojas, M. I., Torres‐García, D., Jiménez-Álvarez, L. A., Vargas‐Alarcón, G., Granados‐Montiel, J., Husain, Z., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.014 · Cited by 35
Study of KIR genes in tuberculosis patients
Méndez, A., Granda, H., Meenagh, A., Contreras, S., Zavaleta, R., Mendoza, M. F., Izquierdo, L., Sarmiento, M. E., Acosta, A., & Middleton, D. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00685.x · Cited by 35
Morin, S. J., Treff, N. R., Tao, X., Scott, R. T., Franasiak, J. M., Juneau, C. R., Maguire, M., & Scott, R. T. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.12.004 · Cited by 34
Role of cancer immunology in chronic myelogenous leukemia
Ureshino, H., Shindo, T., & Kimura, S. H. (2019) · Leukemia Research · doi:10.1016/j.leukres.2019.106273 · Cited by 34
The role of KIR positive NK cells in diseases and its importance in clinical intervention
Asl, K. D., Velaei, K., Rafat, A., Nasrabadi, H. T., Movassaghpour, A. A., Mahdavi, M., & Charoudeh, H. N. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107361 · Cited by 34
Multiple divergent haplotypes express completely distinct sets of class I MHC genes in zebrafish
McConnell, S. C., Restaino, A. C., & de Jong, J. L. O. (2013) · Immunogenetics · doi:10.1007/s00251-013-0749-y · Cited by 34
Natural killer cell‐mediated lysis of freshly isolated human tumor cells
Carlsten, M., Malmberg, K., & Ljunggren, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.24082 · Cited by 37
Evaluation of KIR genes in recurrent miscarriage
Öztürk, Ö. G., Şahin, G. T., Karaçor, E. D. Z., & Güleç, Ü. K. (2012) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-012-9811-1 · Cited by 34
Role ofHLA,KIR,MICA, and Cytokines Genes in Leprosy
Jarduli, L. R., Sell, A. M., Reis, P. G., Sippert, E., Ayo, C. M., Mazini, P. S., Alves, H. V., Teixeira, J. J. V., & Visentainer, J. E. L. (2013) · BioMed Research International · doi:10.1155/2013/989837 · Cited by 34
Natural Killer Cell Tolerance: Control by Self or Self-Control?Preprint
Jaeger, B. N., & Vivier, É. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007229 · Cited by 39
Selection, tuning, and adaptation in mouse NK cell education
Kadri, N., Thanh, T. L., & Höglund, P. (2015) · Immunological Reviews · doi:10.1111/imr.12330 · Cited by 33
MHC and KIR Polymorphisms in Rhesus Macaque SIV Infection
Walter, L., & Ansari, A. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00540 · Cited by 33
Licensing delineates helper and effector NK cell subsets during viral infection
Zamora, A. E., Aguilar, E. G., Sungur, C. M., Khuat, L. T., Dunai, C., Lochhead, G. R., Du, J., Pomeroy, C., Blazar, B. R., Longo, D. L., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.87032 · Cited by 33
Identification of a KIR antisense lncRNA expressed by progenitor cells
Wright, P. W., Huehn, A. R., Cichocki, F. M., Li, H., Sharma, N., Dang, H., Lenvik, T. R., Woll, P. S., Kaufman, D. S., Miller, J. S., et al. (2013) · Genes and Immunity · doi:10.1038/gene.2013.36 · Cited by 33
Natural killer cell receptors and their ligands in liver diseases
Yamagiwa, S., Kamimura, H., & Ichida, T. (2009) · Medical Molecular Morphology · doi:10.1007/s00795-008-0434-7 · Cited by 33
Protective effect of the KIR2DS1 gene in atopic dermatitis
Niepiekło-Miniewska, W., Majorczyk, E., Matusiak, Ł., Gendzekhadze, K., Nowak, I., Narbutt, J., Lesiak, A., Kuna, P., Ponińska, J. K., Pietkiewicz-Sworowska, A., et al. (2013) · Gene · doi:10.1016/j.gene.2013.06.015 · Cited by 33
Nearman, Z. P., Włodarski, M. W., Jankowska, A., Howe, E. C., Narvaez, Y., Ball, E. J., & Maciejewski, J. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06429.x · Cited by 33
Analysis of Binding of KIR3DS1*014 to HLA Suggests Distinct Evolutionary History of KIR3DS1
O’Connor, G. M., Yamada, E., Rampersaud, A., Thomas, R., Carrington, M. N., & McVicar, D. W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002906 · Cited by 32
Immune tolerance at the maternal‐placental interface in healthy pregnancy and pre‐eclampsia
Valencia‐Ortega, J., Saucedo, R., Peña-Cano, M. I., Hernández-Valencia, M., & Cruz-Durán, J. G. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14309 · Cited by 32
Misra, M. K., Prakash, S., Moulik, N. R., Kumar, A., & Agrawal, S. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.10.009 · Cited by 32
Novel nonclassical MHC class Ib genes associated with CD8 T cell development and thymic tumors
Goyos, A., Ohta, Y., Guselnikov, S. V., & Robert, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.01.016 · Cited by 32
Structural insights into activation of antiviral NK cell responses
Finton, K. A. K., & Strong, R. K. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01168.x · Cited by 34
Schellekens, J., Rozemuller, E. H., Petersen, E. J., van den Tweel, J. G., Verdonck, L. F., & Tilanus, M. G. J. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.11.014 · Cited by 32
Johansson, S., Salmon‐Divon, M., Johansson, M. H., Pickman, Y., Brodin, P., Kärre, K., Mehr, R., & Höglund, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006046 · Cited by 32
Abi‐Rached, L., Dorighi, K. M., Norman, P. J., Yawata, M., & Parham, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7943 · Cited by 32
Self-citationReproduction, infection and killer-cell immunoglobulin-like receptor haplotype evolution
Penman, B. S., Moffett, A., Chazara, O., Gupta, S., & Parham, P. (2016) · Immunogenetics · doi:10.1007/s00251-016-0935-9 · Cited by 31
Self-citationCancer treatment and the KIR–HLA system: an overview
Leone, P., Re, V. D., Vacca, A., Dammacco, F., & Racanelli, V. (2017) · Clinical and Experimental Medicine · doi:10.1007/s10238-017-0455-4 · Cited by 31
Maat, W., van der Slik, A. R., Verhoeven, D. H. J., Alizadeh, B. Z., Ly, L. V., Verduijn, W., Luyten, G. P. M., Mulder, A., van Hall, T., Koning, F., et al. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2733 · Cited by 31
The Genetic Aspects of Pre-eclampsia: Achievements and Limitations
Nejatizadeh, A., Stobdan, T., Malhotra, N., & Pasha, M. A. Q. (2008) · Biochemical Genetics · doi:10.1007/s10528-008-9163-9 · Cited by 31
NK cells after transplantation: friend or foe
Hadad, U., Martinez, O. M., & Krams, S. M. (2014) · Immunologic Research · doi:10.1007/s12026-014-8493-4 · Cited by 31
Boerman, G. H., Dam, M. M. V. O.-T., Kraal, K. C. J. M., Santos, S. J., Ball, L. M., Lankester, A. C., Schilham, M. W., Egeler, R. M., & van Tol, M. J. D. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1657-9 · Cited by 31
Signatures of historical demography and pathogen richness on MHC class I genes
Qutob, N., Balloux, F., Raj, T., Liu, H., de Procé, S. M., Trowsdale, J., & Manica, A. (2011) · Immunogenetics · doi:10.1007/s00251-011-0576-y · Cited by 31
Ameres, S., Besold, K., Plachter, B., & Moosmann, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302281 · Cited by 31
Cancer Immunotherapy: A Review
Meiliana, A., Dewi, N. M., & Wijaya, A. (2016) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v8i1.189 · Cited by 31
Cascino, I., Paladini, F., Belfiore, F., Cauli, A., Angelini, C., Fiorillo, M. T., Mathieu, A., & Sorrentino, R. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22820 · Cited by 31
Rodríguez, J., Sáez‐Borderías, A., Munteis, E., Romo, N., Roquer, J., & López‐Botet, M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.06.002 · Cited by 31
Influenza Virus Targets Class I MHC-Educated NK Cells for Immunoevasion
Mahmoud, A. B., Tu, M. M., Wight, A. E., Zein, H. S., Rahim, M. M. A., Lee, S., Sekhon, H. S., Brown, E. G., & Makrigiannis, A. P. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005446 · Cited by 30
Faridi, R. M., Kemp, T. J., Dharmani‐Khan, P., Lewis, V. A., Tripathi, G., Rajalingam, R., Daly, A. S., Berka, N., Storek, J., & Khan, F. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158242 · Cited by 30
Human Natural Killer Receptors, Co‐Receptors, and Their Ligands
Biassoni, R., & Malnati, M. (2018) · Current Protocols in Immunology · doi:10.1002/cpim.47 · Cited by 31
Petitdemange, C., Wauquier, N., Jacquet, J.-M., Theodorou, I. D., Leroy, E. M., & Vieillard, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108798 · Cited by 30
Eissens, D., Schaap, N. P., Preijers, F. W. M. B., Dolstra, H., van Cranenbroek, B., Schattenberg, A., Joosten, I., & van der Meer, A. (2009) · Leukemia · doi:10.1038/leu.2009.269 · Cited by 30
HLA and KIR polymorphisms affect NK-cell anti-tumor activity
Passweg, J. R., Huard, B., Tiercy, J., & Roosnek, E. E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.07.008 · Cited by 30
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation
Velardi, A., Ruggeri, L., Mancusi, A., Burchielli, E., Perruccio, K., Aversa, F., Martelli, M. F., & on behalf of the Immunobiology Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0136-1 · Cited by 30
Wiśniewski, A., Jankowska, R., Passowicz−Muszyńska, E., Wiśniewska, E., Majorczyk, E., Nowak, I., Frydecka, I., & Kuśnierczyk, P. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.07.323 · Cited by 30
Frasier, T. R., Gillett, R. M., Hamilton, P. K., Brown, M. W., Kraus, S. D., & White, B. N. (2013) · Ecology and Evolution · doi:10.1002/ece3.738 · Cited by 30
Klimov, L. O., Ershov, N., Efimov, V. M., Markel, А. L., & Redina, O. E. (2016) · BMC Genetics · doi:10.1186/s12863-015-0307-8 · Cited by 30
Metadata
- Authors
- Parham, P.
- Affiliations
- Stanford University (US)
- Corresponding author
- Parham, Peter
- ORCID
- Parham, Peter
- Venue
- Nature Reviews Immunology
- Published
- 2005-02-18
- Volume
- 5
- Issue
- 3
- Pages
- 201-214
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2008919922
- Cited by
- 1,203
- References
- 125
- Citations by year
- 2026: 28 · 2025: 36 · 2024: 35 · 2023: 23 · 2022: 44 · 2021: 38 · 2020: 43 · 2019: 54 · 2018: 46 · 2017: 50 · 2016: 57 · 2015: 55 · 2014: 57 · 2013: 95 · 2012: 77
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- MHC class I, killer cell immunoglobulin-like receptors, natural killer cells, T cells, infection resistance, autoimmune disease susceptibility, pregnancy complications, hematopoietic stem cell transplantation, human survival, immune system evolution, reproduction
- MeSH terms
- Animals, Autoimmune Diseases, Communicable Diseases, Humans, Lymphocytes, Neoplasms, Receptors, Immunologic, Histocompatibility Antigens Class I, Models, Immunological, Evolution, Molecular, Receptors, KIR
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review